Orphan Reach is a global and full-service CRO that has built a reputation for outstanding clinical research addressing rare diseases. We offer global clinical development services that allow our clients to take their precious IMP from early trials in patients to Marketing Authorization. From Project Management to Clinical Monitoring, Safety & Pharmacovigilance, Quality Assurance, Data Management, and Biostatistics: we provide a seamless CRO service. What makes us stand out is the refinement of our processes and adaptation of services to accommodate clinical trials involving small patient numbers. Dealing efficiently with the unique medical, scientific, clinical, and commercial challenges within the rare disease domain, is what our clients appreciate.
Neox is a privately owned full services clinical CRO. We conduct clinical trials for pharmaceutical, biotechnology, medical device companies and other CRO’s throughout Europe and US. Our services are offered for Phase I-IV. DRUG DEVELOPMENT - Medical Writing, Site Contracting, Clinical Monitoring, Project Management, Pharmacovigilance, Regulatory, Medical Monitoring, Outsourcing. MEDICAL DEVICE DEVELOPMENT PHARMACOVIGILANCE & REGULATORY REAL WORLD EVIDENCE/DATA & HEOR DATA MANAGEMENT & BIOSTATISTICS We offer our services as a full service package or individually as a tailored solution to your specific needs. Where We Are: Years of clinical research experience, understanding local requirements and established relationships with investigators ensures that your trial will always be performed in an optimal setting for high patient enrollment. Neox offices: Czechia, California, Germany, Poland, Hungary, Bulgaria, Slovakia, Romania. Neox also operates in: Austria, Belgium, Estonia, France, Finland, Italy, Latvia, Lithuania, Netherlands, Spain, United Kingdom and others.